+1 Recommend
1 collections
      • Record: found
      • Abstract: found
      • Article: found

      Impaired Copulatory Behaviour of Male Rats with Hyperprolactinaemia Induced by Domperidone or Pituitary Grafts



      S. Karger AG

      Male sexual behaviour, Hyperprolactinaemia, Domperidone, Pituitary grafts

      Read this article at

          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.


          Sexually experienced male CFHB rats, castrated and implanted with testosterone, were chronically treated with domperidone (ca. 5 mg/kg/day). Twice-weekly tests of sexual behaviour showed a significant elevation of both mount latency and ejaculation latency, and suppression of mounting rate after 2–3 weeks of treatment. The number of mounts and intromissions before ejaculation was increased on some tests by domperidone. Experienced male WAG rats, also castrated and testosterone implanted, received three pituitary grafts under the kidney capsule. An increase in ejaculation latency was seen during the first week and then again several weeks after grafting, though implantation of non-endocrine tissue (muscle) into the controls may also have affected behaviour. Both treatments elevated serum prolactin levels, domperidone much more substantially than pituitary grafts. Serum testosterone levels were sustained within the normal intact range by the implants. The weights of the seminal vesicles, ventral prostate and adrenal glands were not significantly altered by either treatment. These experiments show that hyperprolactinaemia induced by two independent methods can retard sexual behaviour in male rats.

          Related collections

          Author and article information

          S. Karger AG
          26 March 2008
          : 35
          : 3
          : 186-193
          Department of Anatomy, University of Cambridge, Cambridge, UK
          123379 Neuroendocrinology 1982;35:186–193
          © 1982 S. Karger AG, Basel

          Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

          Page count
          Pages: 8
          Original Paper


          Comment on this article